Chromocell to present at alliance global partner's healthcare company showcase on tuesday, may 21, 2024

Freehold, n.j., may 13, 2024 (globe newswire) -- chromocell therapeutics corporation (“chromocell”, or the “company”), (nyse american: chro), a pioneer in the development of non-opioid pain treatment therapeutics, today announced that its ceo frank knuettel, will be presenting at alliance global partners healthcare company showcase on tuesday, may 21, 2024.
CHRO Ratings Summary
CHRO Quant Ranking